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Abstract
Background: Two simples scoring systems for a self-completed postal respiratory questionnaire
were developed to identify adults who may have obstructive airways disease. The objective of this
study was to validate these scoring systems.
Method: A two-stage design was used. All adults in two practice populations were sent the
questionnaire and a stratified random sample of respondents was selected to undergo full clinical
evaluation. Three respiratory physicians reviewed the results of each evaluation. A majority
decision was reached as to whether the subject merited a trial of obstructive airways disease
medication. This clinical decision was compared with two scoring systems based on the
questionnaire in order to determine their positive predictive value, sensitivity and specificity.
Results: The PPV (positive predictive value) of the first scoring system was 75.1% (95% CI 68.6–
82.3), whilst that of the second system was 82.3% (95% CI 75.9–89.2). The more stringent second
system had the greater specificity, 97.1% (95% CI 96.0–98.2) versus 95.3% (95% CI 94.0–96.7), but
poorer sensitivity 46.9% (95% CI 33.0–66.8) versus 50.3% (95% CI 35.3–71.6).
Conclusion: This scoring system based on the number of symptoms/risk factors reported via a
postal questionnaire could be used to identify adults who would benefit from a trial of treatment
for obstructive airways disease.
Background
The aim of the study was to validate two simple scoring
systems for a self-completed postal questionnaire de-
signed to identify adult patients likely to have asthma/
COPD (obstructive airways disease).
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It has been reported that asthma is under-diagnosed and
under-treated in adults [1,2]. In the short term this prob-
ably leads to increased morbidity for sufferers, and in the
long term it may have a detrimental effect on their lung
function and clinical state [3]. Chronic obstructive pul-
monary disease is also thought to be under-diagnosed in
adults [4]. This may lead to increased morbidity and the
loss of an effective opportunity for giving smoking cessa-
tion advice. There may be clinical benefits to the individ-
ual and health economic benefits to society from
identifying and treating patients who have asthma or
COPD and who are unknown to the medical services. Be-
fore this hypothesis can be tested, however, mechanisms
for identifying such patients need to be established. Full
clinical review of everyone in a community is neither cost
efficient nor practical. An alternative approach is to use a
screening questionnaire, designed to identify individuals
most likely to have the condition, and therefore most like-
ly to benefit from clinical review.
The Wythenshawe Community Asthma Project (WYCAP)
is a long term prospective study of the natural history of
respiratory symptoms in two general practice populations
in Manchester, UK. One of its aims is to develop a method
for identifying patients in the community with asthma
and COPD as the first stage in evaluating the benefits and
costs of treating such individuals. In 1993 and 1995, post-
al respiratory questionnaire surveys were carried out in
both practice populations. We did not feel that it would
be possible to differentiate asthma from COPD using a
simple postal questionnaire and so two simple scoring
systems were developed, based on the number of symp-
toms/risk factors reported from key questions, both hav-
ing the aim of identifying adults with either asthma or
COPD. This paper examines the validity of these scoring
systems, using data relating to respondents to the 1995
postal survey. A similar exercise has been performed on
children in the two practices [5]. This study had ethical ap-
proval from the local research ethics committee and in-
formed consent was obtained from all subjects attending
for clinical review.
Method
In September 1995 postal questionnaires [2] were sent to
all adults registered with two practices in South Manches-
ter, with reminders sent after four and eight weeks to those
who had not yet responded. From the respondents, a strat-
ified random sample of adults was selected to undergo full
clinical examination. To determine the sample, adults
were first stratified according to the number of symptoms/
risk factors reported from six key questions (Table 1).
Random samples were taken from each of five strata
(those with one to three positive responses were aggregat-
ed for sampling purposes). The sampling fraction for each
stratum was chosen in advance in order to give approxi-
mately equal numbers of subjects with and without ob-
structive airways disease in the overall sample. As this was
a new scoring system, estimates of the expected prevalence
of obstructive airways disease in each stratum had to be
derived empirically from the researchers' clinical experi-
ence. The number from each stratum invited to the clini-
cal review and the number who attended is shown in
Table 2. Subjects were invited via telephone or home visit
by their general practitioner to attend their local hospital
for clinical review.
Clinical assessment
The clinical assessment (carried out by a clinician, TLF) in-
volved a structured medical history and physical examina-
tion. A research assistant performed the investigations,
supervised and assisted by the clinician. Neither individu-
al had access to the postal questionnaire results for the
subject being examined.
The investigations performed have been described in a
previous study [5] and included forced expiratory volume
in one second (FEV1), forced vital capacity (FVC), FEV1 /
FVC, a peak expiratory flow diary, skin prick testing using
Table 1: Six key questions from the respiratory questionnaire and two markers of disease severity
Six key questions:
1) Have you had wheezing or whistling in your chest at any time*?
2) Have you woken up with a feeling of tightness in your chest*?
3) Have you been woken by an attack of shortness of breath at any time*?
4) Have you been woken by an attack of coughing at any time*?
5) Has any person in your family (parents, grandparents, sisters, brothers, or your children) had asthma?
6) Have you ever had hay fever or eczema?
*(in the last 12 months)
Markers of severity:
a) Breathlessness when wheezing was present.
b) Wheezing or whistling without a cold.BMC Family Practice 2003, 4 http://www.biomedcentral.com/1471-2296/4/5
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the skin prick/puncture technique [6] and reversibility
testing to β2 agonists [7]. A bronchial challenge test to his-
tamine was also performed by the YAN technique [8]. A
positive histamine challenge was defined as a fall in FEV1
of 20% from the pre challenge FEV1.
For each subject, three independent consultant chest phy-
sicians were sent full details of the clinical assessment but
excluding the details of the postal questionnaire. The con-
sultants were asked to decide whether the subject merited
a trial of asthma/COPD (obstructive airways disease)
medication. Patients warranting a trial of treatment were
said to have a diagnosis of possible obstructive airways
disease.
The consultants' opinions were compared with two sets of
questionnaire scoring systems chosen in advance on the
basis of clinical experience as likely predictors of obstruc-
tive airways disease:
1) Four or more symptoms/risk factors reported from the
six key questions.
2) Four or more symptoms/risk factors reported from the
six key questions plus at least one marker of severity (Ta-
ble 1).
Statistical analysis
The positive predictive value, sensitivity, specificity and
their confidence intervals were calculated for each scoring
system using the majority consultant opinion as the "gold
standard". The method used was appropriate for the two-
stage process [9]. The prevalence of subjects who would
merit a trial of obstructive airways disease medication was
also estimated using the two-stage process.
Results
Of 10,429 questionnaires sent out in 1995, 7,580 were re-
turned after three mailings. After a 5.5% adjustment for
adults no longer at the mailing address [2], this represent-
ed a 78% response rate. 6947 responses contained suffi-
cient information for the present analyses. 420 adults
were invited for clinical review of whom 202 (48%)
attended.
Agreement between consultants about the decision to
treat is detailed in Table 3. There was unanimous agree-
ment concerning the merits of a trial of treatment in 119
(59.2 %) adults. The majority verdict was used to classify
the remaining subjects.
Table 4 compares the majority expert opinions against the
two sets of questionnaire scoring systems. Of 146 adults
with four or more symptoms/risk factors, 109 (75%) mer-
ited a trial of medication. 100 (82%) of the 122 adults
who reported four or more symptoms/risk factors and
who had a marker of severity were thought by the consult-
ants to merit a trial of asthma medication.
The positive predictive values (PPV), sensitivity and spe-
cificity of the two scoring systems are shown in Table 5.
The PPV for the first scoring system when compared
against the consultants' opinion was 75.1% (95% confi-
dence interval (CI) 68.6–82.3), whilst that of the second
Table 2: Response categories of respondents, those invited for and those attending clinical review
Number of symptoms/risk factors 0 1–3 4 5 6 Total
All respondents 2158 3765 521 355 148 6947
Number invited for clinical review 60 60 150 105 45 420
Number who attended review (% of those invited) 26 (43.3) 30 (50.0) 75 (50.0) 53 (50.5) 18 (40.0) 202 (48.1)
Table 3: Level of consultant agreement Number of adults categorised according to whether they merit a trial of obstructive airways 
disease medication by the level of consultant agreement.
Meriting a trial of obstructive airways disease medication
Consultant agreement Yes No Total
All agreed 73 46 119
2 out of 3 agreed 43 39 82
Final categorisation 116 85 201
One subject was not categorised by one of the consultants and the other two disagreed on the decision on whether a trial of obstructive airways 
disease treatment was indicated so no majority decision could be made. This individual was excluded from analysis.BMC Family Practice 2003, 4 http://www.biomedcentral.com/1471-2296/4/5
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system was 82.3% (95% CI 75.9–89.2). The more strin-
gent second scoring system had a greater specificity but
poorer sensitivity than the first scoring system.
The prevalence of adults "meriting a trial of obstructive
airways disease therapy" (a surrogate for obstructive air-
ways disease) in our survey was calculated [5] to be 22%
(95% CI 15.5–31.4).
Discussion
Two simple scoring systems, (based on the number of
symptoms/risk factors reported on a respiratory question-
naire) produced high positive predictive values when
compared with majority opinion of three respiratory phy-
sicians regarding possible obstructive airways disease.
Two important sources of selection bias could have oc-
curred. First, non-respondents to the questionnaire survey
could have been materially different from respondents.
This was examined after the first questionnaire survey in
1993, when a comparison was made between the practice
medical records of a random sample of 100 respondents
and 100 non-respondents. No important differences were
found with respect to age, gender, and total number of
consultations and consultations for respiratory problems
in the previous year. There is no reason to suspect that the
situation was different in 1995. Second, the adults attend-
ing for clinical review may have been different from those
who were invited but who did not attend. These two
groups were compared with respect to their age, gender
and the number of cigarettes smoked as reported on the
questionnaire. No significant differences were found be-
tween the two groups.
The purpose of a screening test is to identify individuals
with a good chance of having disease and who require
further clinical assessment to confirm or refute the diag-
nosis. When defining the threshold at which a screening
test is deemed to be positive, consideration has to be tak-
en of the balance between false positive results (which can
lead to extra distress because of unnecessary further inves-
tigations) and false negatives (which result in some cases
of disease being missed). The positive predictive value of
a test reflects the frequency of disease in those with a pos-
itive screening test. The cost effectiveness of a screening
programme will depend on the cut-off values chosen for
the screening procedure as these determine the number of
new cases detected and requiring treatment, unnecessary
investigations undertaken etc.
When assessing a screening test it can be difficult to know
what diagnostic standard to use, particularly for condi-
tions such as obstructive airways disease which do not
have a universally accepted clinical definition. In our
study, we defined adults as having possible obstructive
airways disease if the majority opinion of three consultant
physicians was that a trial of treatment for obstructive air-
ways disease was merited (majority decisions of specialists
Table 4: Comparison between majority expert opinions and questionnaire scoring systems
Categories of score "Meriting a trial of 
medication"
"Not meriting a trial of 
medication"
Total
All responses 116 85 201*
System 1 Four or more symptoms/risk factors 109 37 146
Fewer than four or more symptoms/risk factors 7 48 55
System 2 Four or more symptoms/risk factors plus one marker of severity 100 22 122
Other responses- 16 63 79
* One subject was not categorised by one of the consultants and the other two disagreed on the decision on whether a trial of obstructive airways 
disease treatment was indicated so no majority decision could be made. This individual was excluded from analysis.
Table 5: Positive predictive value, sensitivity and specificity of the two scoring systems Discriminative properties of two scoring systems 
for questionnaire responses compared with the majority expert opinion about whether the patients merit a trial of obstructive airways 
disease therapy.
Scoring system 1. Four or more symptoms/risk factors 2. Four or more symptoms/risk factors plus one marker of severity
PPV % [95% CI] 75.1 [68.6–82.3] 82.3 [75.9–89.2]
Sensitivity % [95% CI] 50.3 [35.3–71.6] 46.9 [33.0–66.8]
Specificity % [95% CI] 95.3 [94.0–96.7] 97.1 [96.0–98.2]
PPV = Positive predictive value CI = Confidence intervalBMC Family Practice 2003, 4 http://www.biomedcentral.com/1471-2296/4/5
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has been used in previous studies to diagnose asthma)
[1,5]. Many clinicians would probably agree that it is rea-
sonable to assess an adult who might merit a trial of ob-
structive airways disease treatment. Comparing the two
scoring systems against this "standard", we were able to
determine the test characteristics (sensitivity, specificity
and positive predictive value) of each system. The more
stringent system (four or more symptoms/risk factors plus
a marker of severity) had a greater positive predictive val-
ue and greater specificity (so gave fewer false positive re-
sults) than the less stringent system (four or more
symptoms/risk factors alone), but at the cost of reduced
sensitivity (more cases were missed).
Any system, which increased sensitivity, would almost
certainly have reduced positive predictive value probably
resulting in and unacceptable rate of false positives. In
contrast with screening for malignant conditions when
detection of all cases is of prime importance (i.e. high sen-
sitivity), it could be argued that in population screening
for diseases such as asthma/COPD the PPV carries more
weight than sensitivity.
A recent article by Grimes and Schultz [10] illustrates this
point:
"Although sensitivity and specificity are of interest to pub-
lic-health policymakers, they are of little use to the clini-
cian. Stated alternatively, sensitivity and specificity
(population measures) look backward (at results gathered
over time). Clinicians have to interpret test results to those
tested. Thus what clinicians need to know are the predic-
tive values of the test (individual measures, which look
forward)".
In a previous paper [2], 1112 patients (13.8% of respond-
ers) were identified positively by the screening question-
naire. The PPV would indicate that approximately 834 of
these had obstructive airways disease. Further, 529 of
those who screened positively had no recorded diagnosis
of obstructive airways disease or received inhaled medica-
tion in the previous 12 months. Thus despite the disad-
vantage of a relatively low sensitivity for the scoring
system significant numbers of patients with obstructive
airways disease would be identified. It should be noted
that the prevalence of adults "meriting a trial of obstruc-
tive airways disease therapy" in our survey was calculated
[5] to be 22% (95% CI 15.5–31.4). This may be an over-
estimate of the true prevalence of obstructive airways dis-
ease as it will include patients who would not benefit
from a trial of treatment.
The three specialists reviewing the clinical information re-
lied on detailed written data supplied to them by the re-
search team; they did not have direct contact with patient.
Neither the experts nor the examining team were aware of
the results of the postal questionnaire at the time of their
involvement in the study. Total agreement by the consult-
ants on whether a subject warranted a trial of medication
was reached in 59.2% of adults. Difficulties in making a
diagnosis without personally seeing the patient may also
have contributed to disagreement between consultants al-
though it is likely that some difference of opinion would
have persisted even with personal examination. Expert
opinion concerning asthma diagnosis has been used to
define asthma in previous epidemiological studies
[1,11,12]., whilst others have used patient recall of asth-
ma diagnosis or treatment when measuring prevalence of
the disease or its underdiagnosis [13]. The majority of di-
agnostic decisions are made in primary care and we ac-
knowledge that choosing three consultant respiratory
physicians as the diagnostic gold standard therefore has
limitations. They were however chosen to reflect a spread
of secondary and tertiary respiratory opinions.
An advantage of the scoring systems used was their sim-
plicity. Techniques such as discriminant analysis and lo-
gistic regression could have been used to assess the
predictive value of each question and a different scoring
system developed from them. This would have the disad-
vantage that validation would then have been based on
the same data as was used to derive the scoring system and
therefore would tend to be over optimistic. In addition
the scoring system might be more difficult to implement.
In clinical practice, a simple scoring system to identify pa-
tients requiring further review is attractive. Choices about
which system to use will depend on a number of factors;
the balance between positive predictive value and sensi-
tivity of each system and available health care resources. It
is important to remember that if this questionnaire were
to be used in another setting the positive predictive value
would have to be recalculated as this value is dependent
on the prevalence of disease in the population studied.
Conclusions
When assessed against the majority expert opinion of
"meriting a trial of obstructive airways disease medica-
tion", two simple scoring systems based on responses to a
brief postal questionnaire provided a good method for
identifying adults likely to benefit from a trial of treat-
ment for obstructive airways disease and so warranting
clinical review.
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